(Q46528181)

English

Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis

scientific article published in August 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18568646

Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18568646

oligodendrocyte

1 reference

based on heuristic

inferred from title

methylprednisolone

1 reference

based on heuristic

inferred from title

Frank Alderuccio

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18568646

author name string

James Chan

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18568646

Ee Jun Ban

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18568646

Keng Hao Chun

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18568646

Shunhe Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18568646

Jonathan McQualter

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18568646

Claude Bernard

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18568646

Ban-Hock Toh

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18568646

publication date

1 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18568646

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18568646

41

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18568646

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18568646

405-413

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18568646

Multiple sclerosis--the plaque and its pathogenesis

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

Multiple sclerosis: a battle between destruction and repair

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

Modular transcriptional activity characterizes the initiation and progression of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

Management of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

The mechanism of action of methylprednisolone in the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

The effect of prednisolone on gastric mucosal histology, gastric secretion, and vitamin B 12 absorption in patients with pernicious anemia

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

Aldosterone and prednisolone control of cochlear function in MRL/MpJ-Fas(lpr) autoimmune mice

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

Effect of cyclosporin A, silica quartz dust, and protease inhibitors on virus-induced demyelination

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study.

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

Induction of tolerance to self-antigens using genetically modified bone marrow cells

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

Gene therapy strategies towards immune tolerance to treat the autoimmune diseases

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

Tolerance established in autoimmune disease by mating or bone marrow transplantation that target autoantigen to thymus.

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

Immunopathology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

The NOD mouse: a model of immune dysregulation

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes.

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

Enhancing central nervous system remyelination in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

Remyelinating strategies for the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1080%2F08916930802011258

21 January 2018

Identifiers

10.1080/08916930802011258

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18568646

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18568646

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46528181&oldid=2116245041"